Cellares announced multiple strategic technology partners Sept. 17 to advance its Cell Q. NJBIZ has reported extensively on the cell therapy manufacturer, which operates a Smart Factory in Bridgewater ...
Technology Adoption Program (TAP) program success demonstrates the ability of Cellares’ IDMO Smart Factory to automate, lower costs and scale out manufacturing for Cabaletta Bio’s clinical-stage CAR T ...
While the Cell Shuttle automates cell therapy manufacturing, the Cell Q™ automates quality control at high throughput, both for in-process and release QC. Cell Shuttles™ and Cell Qs™ will be deployed ...
Current cell therapies like CAR-T cells lack the precision to distinguish between healthy and diseased tissue, leading to limited effectiveness and potential side effects. One of the most significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results